Biodexa Pharmaceuticals Holds First Round Table Meeting In France To Expand Support For Familial Adenomatous Polyposis Patients, Prescribers
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers is pleased to announce that it has
Biodexa is meeting with doctors and patients in France to learn how to better help people with a rare condition that can lead to cancer. This shows the company is working to understand what patients need before selling any medicines.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.